Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable respo…
Biotechnology
US, New York [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Indaptus Therapeutics, Inc. (INDP) to it's peer group.
Peer Group
RZLT BWV RNXT ABVC KPRX HILS MTCR BTTX NTRB ZIVO TPST KTTA ANEB FBRX ASMB QNRX LGVN REVB CMRA
Compare Together
Loading...